Explore 3 Stock Ideas & Industry Insights Download Free Report

Raia Drogasil SA ADR

Company price
2.78 USD 0.09 ( 3.35%)
Last update at 2026-11-06T19:29:00Z
VOLUME
723
Market Cap
6644.44M
P/E
22.35

Momentum Score

…

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.78
Low
2.78
High
52 Week Price Range
3.16
Low
5.16
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
2.69
Dividend Yield
2.26%
Revenue TTM
46533.85M
Revenue Per Share
28.53
Gross Profit TTM
14098.83M
Debt / Equity
1.21
ROE
19.99%
Net Debt
8320.27M
ROCE
16.93%
Diluted EPS TTM
0.17

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1419.61M 1415.71M 1216.69M 1193.21M 987.26M
Minority interest -3.38M -11.51M -32.17M -18.86M -12.20M
Net income 1271.39M 1197.69M 1054.97M 996.11M 751.93M
Selling general administrative 1570.39M 1567.11M 1503.53M 1249.85M 912.33M
Selling and marketing expenses 8719.37M 7627.56M 6689.27M 5805.99M 4966.82M
Gross profit 10736.72M 11549.72M 10207.36M 8809.47M 7206.17M
Reconciled depreciation 1048.93M 911.97M 797.69M 1515.54M 1327.11M
Ebit 2585.62M 2228.43M 1954.48M 1479.92M 1222.39M
Ebitda 4559.12M 3140.39M 2752.17M 2995.46M 2549.50M
Depreciation and amortization 1973.50M 911.97M 797.69M 1515.54M 1327.11M
Operating income 2585.62M 2367.17M 2080.49M 1479.92M 1222.39M
Other operating expenses 40795.61M 36497.28M 31893.30M 27233.22M 22752.50M
Interest expense 1052.25M 812.72M 737.79M 292.69M 228.23M
Tax provision 147.81M 206.51M 129.55M 178.24M 223.13M
Interest income 0.00M 0.02M 0.04M 0.49M 0.06M
Net interest income -1314.91M -969.15M -916.58M -673.91M -388.72M
Income tax expense 144.91M 206.51M 129.55M 178.24M 223.13M
Total revenue 43381.23M 38864.46M 33973.79M 29067.38M 24127.00M
Total operating expenses 8151.10M 9182.54M 8126.88M 6975.30M 5831.67M
Cost of revenue 32644.51M 27314.74M 23766.43M 20257.91M 16920.83M
Total other income expense net -1166.01M -951.46M -863.80M -286.71M -235.13M
Net income from continuing ops 1300.24M 1209.20M 1087.14M 1014.97M 764.13M
Net income applicable to common shares - - - 996.11M 751.93M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 25461.04M 22141.69M 20094.41M 17185.31M 14775.51M
Intangible assets 964.47M 968.98M 860.62M 657.94M 526.48M
Other current assets 120.94M 1043.93M 866.99M 266.88M 290.81M
Total liab 18128.76M 15699.50M 14066.11M 11782.36M 10056.70M
Total stockholder equity 7318.45M 6428.77M 5956.00M 5340.86M 4677.67M
Other current liab 1753.77M 1506.63M 1164.40M 1162.59M 926.59M
Common stock 4747.62M 4000.00M 4000.00M 2500.00M 2500.00M
Capital stock 4750.00M 4000.00M 4000.00M 2500.00M 2500.00M
Retained earnings 283.04M 2246.43M 1794.97M 2716.77M 2072.98M
Other liab - - - 302.94M 295.39M
Good will 1086.06M 1056.63M 1056.63M 1080.17M 959.77M
Other assets 0.00M - - 290.79M 239.91M
Cash 509.36M 528.00M 412.32M 433.54M 356.12M
Total current liabilities 10188.78M 9223.47M 8079.50M 6367.17M 5896.19M
Current deferred revenue - - 1192.46M 890.92M 695.48M
Net debt 8320.27M 7167.21M 6655.14M 5624.37M 4822.00M
Short term debt 1529.28M 1585.21M 1463.07M 945.66M 1313.00M
Short long term debt 508.14M 637.11M 604.60M 186.36M 613.83M
Short long term debt total 8829.63M 7695.22M 7067.46M 6057.91M 5178.12M
Other stockholder equity -104.08M 10.88M 66.79M 2840.86M 2177.67M
Property plant equipment - - - 5574.86M 5329.59M
Total current assets 14896.97M 12703.71M 11561.67M 9577.07M 7718.92M
Net tangible assets - - - 3602.75M 3191.42M
Short term investments 19.11M 15.71M -478.75M - -
Net receivables 4676.02M 2708.65M 3130.39M 2750.59M 1954.19M
Long term debt 3359.62M 2656.82M 2526.10M 2131.55M 891.39M
Inventory 9571.54M 8407.43M 7197.43M 6126.06M 5117.80M
Accounts payable 6905.73M 5815.08M 5091.45M 4258.92M 3656.61M
Accumulated other comprehensive income 2287.80M 171.46M 94.24M - -
Non currrent assets other 261.77M 567.35M 500.07M 284.91M 191.70M
Non current assets total 10564.07M 9437.98M 8532.74M 7608.24M 7056.58M
Capital lease obligations 4966.31M 4401.28M 3936.76M 3740.01M 3672.90M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -1412.91M -1307.03M -1229.58M -12.64M
Change to liabilities - - - 611.54M 390.75M
Total cashflows from investing activities -1378.13M -1412.91M -1307.03M -1229.58M -885.95M
Net borrowings 536.13M 163.87M 789.17M -51.17M -850.58M
Total cash from financing activities -1022.80M -383.99M 323.27M -375.25M -1188.83M
Change to operating activities - - - 232.94M 245.15M
Net income 1362.49M 1275.03M 1312.19M 1193.21M 987.26M
Change in cash 41.26M 115.68M -21.22M 77.42M -524.24M
Begin period cash flow 468.10M 412.32M 433.54M 356.12M 880.36M
End period cash flow 509.36M 528.00M 412.32M 433.54M 356.12M
Total cash from operating activities 2382.91M 1912.58M 962.54M 1682.26M 1550.55M
Depreciation 1973.50M 911.97M 797.69M 1515.54M 1327.11M
Other cashflows from investing activities -2.76M -11.44M 0.15M -0.80M -18.45M
Dividends paid 639.94M 474.57M 465.90M 324.08M 265.02M
Change to inventory -1138.06M -1235.04M -1069.93M -1035.34M -896.81M
Change to account receivables -739.41M 463.81M -892.41M -583.60M -158.09M
Sale purchase of stock 0.00M -73.28M 0.00M 0.00M -73.23M
Other cashflows from financing activities -918.99M -474.57M 822.70M 293.24M -597.96M
Change to netincome - - - 100.63M -77.82M
Capital expenditures 1375.42M 1283.65M 1304.58M 1188.78M 855.60M
Change in working capital -984.71M -111.25M -1465.36M -934.67M -455.00M
Stock based compensation 27.98M 38.03M 33.22M 22.60M 15.09M
Other non cash items 3.65M -201.20M 284.81M -114.43M -323.91M
Free cash flow 1007.49M 628.93M -342.04M 493.47M 694.95M

Peer Comparison*

Sector: Healthcare Industry: Pharmaceutical Retailers

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RADLY
Raia Drogasil SA ADR
0.09
3.35%
2.78 22.35 24.69 0.14 4.59 0.90 10.93
JDHIF
JD Health International Inc
-
-%
4.79 15.09 15.11 0.18 1.52 0.59 6.26
ALBBY
Alibaba Health Information Technology Limited
-
-%
7.65 34.43 19.84 0.29 3.79 1.73 25.72
ALBHF
Alibaba Health Information Technology Limited
-
-%
0.33 17.35 16.69 0.16 2.11 0.89 13.04
RTEZ
Rest EZ Inc.
-
-%
70.00 - - 385518.44 5.92 - -

Profile*

Raia Drogasil SA ADR

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

Av. Corifeu de Azevedo Marques, 3097, São Paulo, SP, Brazil, 05339-900

55 11 3769 5678

75594

Name Title Year Born
Mr. Marcílio D'Amigo Pousada CEO & Member of Exec. Board 1965
Mr. Antonio Carlos Coelho VP of Fin. & Admin. and Member of Exec. Board NA
Mr. Eugênio De Zagottis VP of Corp. Planning, IR, M&A and Member of Exec. Board NA
Mr. Marcello De Zagottis VP of Commercial & Marketing and Member of Exec. Board NA
Mr. Fernando Kozel Varela VP of Digital Transformation & Member of Exec. Board NA
Mr. Renato Cepollina Raduan VP of Store, Multichannel & Expansion Operations and Member of Exec. Board NA
Ms. Maria Susana De Souza VP of People, Culture & Sustainability and Member of Exec. Board NA
Mr. Bruno Wright Pipponzi VP of Health Bus. & Member of Exec. Board NA
Ligia Maria Mendes Controllership Director & Accountant In charge NA
Gabriel Rozenberg IR & Corp. Planning Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…